Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR1 | P21453 | 3/20 | 0.40 |
| ▸ | S1PR3 | Q99500 | 3/20 | 0.40 |
| ▸ | S1PR5 | Q9H228 | 3/20 | 0.40 |
| ▸ | GNAO1 | P09471 | 5/20 | 0.40 |
| ▸ | GNAI3 | P08754 | 4/20 | 0.40 |
| ▸ | GNAI1 | P63096 | 4/20 | 0.40 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.36 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.36 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.36 |
| ▸ | LSS | P48449 | 2/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.35 |
| ▸ | GUSB | P08236 | 2/20 | 0.34 |
| ▸ | EBP | Q15125 | 1/20 | 0.34 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14156564 | 0.90 | CYP1A2 (0.35) | S1PR1S1PR3S1PR5GNAO1GNAI3 | |
| SCHEMBL14664303 | 0.82 | SLC6A3 (0.33) | SIGMAR1 | |
| SCHEMBL26814535 | 0.82 | SLC6A3 (0.33) | SIGMAR1 | |
| SCHEMBL9801833 | 0.82 | SLC6A3 (0.33) | SIGMAR1 | |
| SCHEMBL23676432 | 0.80 | ALDH1A1 (0.43) | S1PR1S1PR3S1PR5GNAO1GNAI3 | |
| SCHEMBL21066228 | 0.80 | — | — | |
| SCHEMBL21216990 | 0.77 | — | — | |
| SCHEMBL14156572 | 0.77 | SIGMAR1 (0.37) | SIGMAR1 | |
| SCHEMBL18871727 | 0.76 | GNAI3 (0.48) | S1PR1S1PR3S1PR5GNAO1GNAI3 | |
| SCHEMBL18402637 | 0.76 | GNAI3 (0.48) | S1PR1S1PR3S1PR5GNAO1GNAI3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5601750-A | CONTAINING ENZYMATIC HYDROGEN PEROXIDE GENERATING SYSTEM, IRON OR MANGANESE COORDINATION COMPLEX BLEACH CATALYST, ENZYMATIC ALDEHYDE DECOMPOSING SYSTEM COMPRISING INTACT YEAST CELLS | LEVER BROTHERS COMPANY, DIVISION OF CONOPCO, INC. (US) | 1997-02-11 | — | — | US | claimed |
| US-5314635-A | Macrocyclic organonitrogen ligand | LEVER BROTHERS COMPANY, DIVISION OF CONOPCO, INC. (US) | 1994-05-24 | — | — | US | claimed |
| US-12577505-B2 | Granules comprising protonated triazacyclic compounds and bleaching agent and cleaning agent comprising the same | CATEXEL GMBH (DE) | 2026-03-17 | — | — | US | disclosed |
| EP-4256018-B1 | GRANULES COMPRISING PROTONATED TRIAZACYCLIC COMPOUNDS AND BLEACHING AGENT AND CLEANING AGENT COMPRISING THE SAME | WeylChem Performance Products GmbH (DE) | 2025-07-16 | — | — | EP | disclosed |
| EP-4512881-A1 | LIQUID FORMULATION COMPRISING AN ALCOHOL AND HIGHLY WATER SOLUBLE MANGANESE COMPLEX SALT CATALYST, BLEACHING FORMULATION AND CLEANING AGENT COMPRISING THE SAME | Catexel GmbH (DE) | 2025-02-26 | — | — | EP | disclosed |
| EP-4512880-A1 | LIQUID FORMULATION COMPRISING AN ALCOHOL AND HIGHLY WATER SOLUBLE MANGANESE COMPLEX SALT CATALYST, BLEACHING FORMULATION AND CLEANING AGENT COMPRISING THE SAME | WeylChem Performance Products GmbH (DE) | 2025-02-26 | — | — | EP | disclosed |
| CN-119490893-A | Liquid formulations comprising alcohol and high water-soluble manganese complex salt catalysts, bleaching formulations and cleaners comprising the same | 卡特赛尔有限公司 | 2025-02-21 | — | — | CN | disclosed |
| US-20250059474-A1 | Liquid formulation comprising an alcohol and highly water soluble manganese complex salt catalyst, bleaching formulation and cleaning agent comprising the same | CATEXEL GMBH (DE) | 2025-02-20 | — | — | US | disclosed |
| US-20240034962-A1 | GRANULES COMPRISING PROTONATED TRIAZACYCLIC COMPOUNDS AND BLEACHING AGENT AND CLEANING AGENT COMPRISING THE SAME | CATEXEL GMBH (DE) | 2024-02-01 | — | — | US | disclosed |
| US-20230416658-A1 | COMPOSITIONS COMPRISING PROTONATED TRIAZACYCLIC COMPOUNDS AND MANGANESE(II) ACETATE, MANUFACTURING THEREOF, AND BLEACHING AND CLEANING AGENT COMPRISING SAME | CATEXEL GMBH (DE) | 2023-12-28 | — | — | US | disclosed |
| EP-4296344-A1 | COMPOSITIONS COMPRISING PROTONATED TRIAZACYCLIC COMPOUNDS AND MANGANESE(II) ACETATE, MANUFACTURING THEREOF, AND BLEACHING AND CLEANING AGENT COMPRISING SAME | WeylChem Performance Products GmbH (DE) | 2023-12-27 | — | — | EP | disclosed |
| WO-1995006710-A1 | BLEACH CATALYST COMPOSITION | UNILEVER PLC (GB) | 1995-03-09 | — | — | WO | disclosed |
| WO-1995006711-A1 | BLEACH CATALYST COMPOSITION | UNILEVER PLC (GB) | 1995-03-09 | — | — | WO | disclosed |
| WO-1994024251-A1 | PARTICULATE BLEACHING OR CLEANING COMPOSITIONS CONTAINING ALUMINOSILICATES | UNILEVER PLC (GB) | 1994-10-27 | — | — | WO | disclosed |
| WO-1994021775-A1 | DETERGENT COMPOSITIONS | UNILEVER PLC (GB) | 1994-09-29 | — | — | WO | disclosed |
| EP-0616029-A1 | Bleach and detergent compositions | UNILEVER N.V. (NL) | 1994-09-21 | — | — | EP | disclosed |
| US-5314635-A | Macrocyclic organonitrogen ligand | LEVER BROTHERS COMPANY, DIVISION OF CONOPCO, INC. (US) | 1994-05-24 | — | — | US | disclosed |
| WO-1994009104-A1 | DETERGENT COMPOSITION | UNILEVER PLC (GB) | 1994-04-28 | — | — | WO | disclosed |
| EP-0549271-A1 | Bleach activation | UNILEVER PLC (GB) | 1993-06-30 | — | — | EP | disclosed |
| EP-0549272-A1 | Bleach activation | UNILEVER PLC (GB) | 1993-06-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12577505-B2 | Granules comprising protonated triazacyclic compounds and bleaching agent and cleaning agent comprising the same | HBG2, HBG1, BLM | S1PR1 3745/4885S1PR3 3971/4885S1PR5 3982/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.